Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 7.2% year on year to $142 million. On the other hand, next ...
Shareholders of Exponent, Inc. ( NASDAQ:EXPO ) will be pleased this week, given that the stock price is up 11% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results